None of that matters, what matters is that Steripath is never going to become standard of care, and the company will go out of business in the next six months. All of those large egos will be on the unemployment line. The lower priced more simplistic blood culture reduction company will go on to become the standard of care. Hospitals aren't interested in what Magnolia is selling.
